{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:50:33Z","timestamp":1794293433643,"version":"4.9.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05051-6","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:06:37Z","timestamp":1782777997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non-HDL-to-HDL-cholesterol ratio and metabolic dysfunction\u2013associated steatotic liver disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Samar F.","family":"Patankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash V. A. K.","family":"Ramdass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"5051_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3350\/cmh.2022.0239","volume":"28","author":"MH Le","year":"2022","unstructured":"Le MH, Yeo YH, Zou B, Barnet S, Henry L, Cheung R, et al. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach. Clin Mol Hepatol. 2022;28:841\u201350. https:\/\/doi.org\/10.3350\/cmh.2022.0239.","journal-title":"Clin Mol Hepatol"},{"key":"5051_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatol Baltim Md. 2023;78:1966\u201386. https:\/\/doi.org\/10.1097\/HEP.0000000000000520.","journal-title":"Hepatol Baltim Md"},{"key":"5051_CR3","doi-asserted-by":"publisher","first-page":"100375","DOI":"10.1016\/j.metop.2025.100375","volume":"27","author":"SK Ahmed","year":"2025","unstructured":"Ahmed SK, Mohammed RA. Obesity: Prevalence, causes, consequences, management, preventive strategies and future research directions. Metab Open. 2025;27:100375. https:\/\/doi.org\/10.1016\/j.metop.2025.100375.","journal-title":"Metab Open"},{"key":"5051_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12889-025-21757-w","volume":"25","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang Y, Luo D, Chen B, Lai C, He C, et al. Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiometabolic multimorbidity among middle-aged and older adults in China. BMC Public Health. 2025;25:570. https:\/\/doi.org\/10.1186\/s12889-025-21757-w.","journal-title":"BMC Public Health"},{"key":"5051_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/jch.13038","volume":"19","author":"J Wen","year":"2017","unstructured":"Wen J, Zhong Y, Kuang C, Liao J, Chen Z, Yang Q. Lipoprotein ratios are better than conventional lipid parameters in predicting arterial stiffness in young men. J Clin Hypertens Greenwich Conn. 2017;19:771\u20136. https:\/\/doi.org\/10.1111\/jch.13038.","journal-title":"J Clin Hypertens Greenwich Conn"},{"key":"5051_CR6","doi-asserted-by":"publisher","first-page":"35993","DOI":"10.1038\/s41598-025-19856-0","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Jing Z, Liu Z, Lai A, Tan G, Yan BP. Baseline and longitudinal patterns of Non-HDL-C to HDL-C ratio (NHHR) and major adverse cardiovascular events in peripheral artery disease. Sci Rep. 2025;15:35993. https:\/\/doi.org\/10.1038\/s41598-025-19856-0.","journal-title":"Sci Rep"},{"key":"5051_CR7","doi-asserted-by":"publisher","unstructured":"Lucaciu RL, Coste SC, Hangan AC, Iancu M, Or\u0103\u0219an OH, Cozma A, et al. Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/ijms26125717.","DOI":"10.3390\/ijms26125717"},{"key":"5051_CR8","doi-asserted-by":"publisher","first-page":"1002099","DOI":"10.3389\/fendo.2022.1002099","volume":"13","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Yang N, Fu H, Yuan G, Chen Y, Du T, et al. Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement. Front Endocrinol. 2022;13:1002099. https:\/\/doi.org\/10.3389\/fendo.2022.1002099.","journal-title":"Front Endocrinol"},{"key":"5051_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12876-024-03525-z","volume":"24","author":"Y Hong","year":"2024","unstructured":"Hong Y, Chen X, Yuan H, Huang Z, Tao S, Xie F, et al. Novel non-HDLc\/HDLc ratio for predicting MASLD: a cross-sectional study in a Chinese health screening population. BMC Gastroenterol. 2024;24:439. https:\/\/doi.org\/10.1186\/s12876-024-03525-z.","journal-title":"BMC Gastroenterol"},{"key":"5051_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12967-023-04047-0","volume":"21","author":"S Lu","year":"2023","unstructured":"Lu S, Xie Q, Kuang M, Hu C, Li X, Yang H, et al. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. J Transl Med. 2023;21:192. https:\/\/doi.org\/10.1186\/s12967-023-04047-0.","journal-title":"J Transl Med"},{"key":"5051_CR11","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1038\/s41598-025-90773-y","volume":"15","author":"B Li","year":"2025","unstructured":"Li B, Liu Y, Ma X, Guo X. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hepatic steatosis and liver fibrosis among US adults based on NHANES. Sci Rep. 2025;15:6527. https:\/\/doi.org\/10.1038\/s41598-025-90773-y.","journal-title":"Sci Rep"},{"key":"5051_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"5051_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2020-111649","author":"KS Taylor","year":"2021","unstructured":"Taylor KS, Mahtani KR, Aronson JK. Dealing with categorical risk data when extracting data for meta-analysis. BMJ Evid-Based Med. 2021. https:\/\/doi.org\/10.1136\/bmjebm-2020-111649. :bmjebm-2020-111649.","journal-title":"BMJ Evid-Based Med"},{"key":"5051_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"key":"5051_CR15","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088\u2013101.","journal-title":"Biometrics"},{"key":"5051_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341x.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455\u201363. https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00455.x.","journal-title":"Biometrics"},{"key":"5051_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"G Wells","year":"2011","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson je. The Newcastle-Ottawa Scale (NOS) for assessing the quality of case-control studies in meta-analyses. Eur J Epidemiol. 2011;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"5051_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/jre.13405","author":"MC Carra","year":"2025","unstructured":"Carra MC, Romandini P, Romandini M. Risk of Bias Evaluation of Cross-Sectional Studies: Adaptation of the Newcastle-Ottawa Scale. J Periodontal Res. 2025. https:\/\/doi.org\/10.1111\/jre.13405. ;n\/a n\/a.","journal-title":"J Periodontal Res"},{"key":"5051_CR19","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490. https:\/\/doi.org\/10.1136\/bmj.328.7454.1490.","journal-title":"BMJ"},{"key":"5051_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12876-025-03659-8","volume":"25","author":"X-M Ma","year":"2025","unstructured":"Ma X-M, Guo Y-M, Jiang S-Y, Li K-X, Zheng Y-F, Guo X-G, et al. Potential predictive role of Non-HDL to HDL Cholesterol Ratio (NHHR) in MASLD: focus on obese and type 2 diabetic populations. BMC Gastroenterol. 2025;25:79. https:\/\/doi.org\/10.1186\/s12876-025-03659-8.","journal-title":"BMC Gastroenterol"},{"key":"5051_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1080\/00365520500319591","volume":"41","author":"S Lee","year":"2006","unstructured":"Lee S, Jin Kim Y, Yong Jeon T, Hoi Kim H, Woo Oh S, Park Y, et al. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: A cross-sectional case-control study. Scand J Gastroenterol. 2006;41:566\u201372. https:\/\/doi.org\/10.1080\/00365520500319591.","journal-title":"Scand J Gastroenterol"},{"key":"5051_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.47102\/annals-acadmedsg.V38N1p15","volume":"38","author":"C-C Fu","year":"2009","unstructured":"Fu C-C, Chen M-C, Li Y-M, Liu T-T, Wang L-Y. The Risk Factors for Ultrasound-diagnosed Non-alcoholic Fatty Liver Disease Among Adolescents. Ann Acad Med Singap. 2009;38:15\u201321. https:\/\/doi.org\/10.47102\/annals-acadmedsg.V38N1p15.","journal-title":"Ann Acad Med Singap"},{"key":"5051_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1055\/s-0043-118667","volume":"126","author":"A Klisic","year":"2018","unstructured":"Klisic A, Isakovic A, Kocic G, Kavaric N, Jovanovic M, Zvrko E, et al. Relationship between Oxidative Stress, Inflammation and Dyslipidemia with Fatty Liver Index in Patients with Type 2 Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2018;126:371\u20138. https:\/\/doi.org\/10.1055\/s-0043-118667.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"5051_CR24","doi-asserted-by":"publisher","first-page":"e14131","DOI":"10.1111\/ijcp.14131","volume":"75","author":"H Tutunchi","year":"2021","unstructured":"Tutunchi H, Naeini F, Ebrahimi-mameghani M, Mobasseri M, Naghshi S, Ostadrahimi A. The association of the steatosis severity, NAFLD fibrosis score and FIB\u20104 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross\u2010sectional study. Int J Clin Pract. 2021;75:e14131. https:\/\/doi.org\/10.1111\/ijcp.14131.","journal-title":"Int J Clin Pract"},{"key":"5051_CR25","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3390\/diagnostics12102426","volume":"12","author":"IC Efrem","year":"2022","unstructured":"Efrem IC, Mo\u021ba M, Vladu IM, Mitrea A, Clenciu D, Timofticiuc DCP, et al. A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes. Diagnostics. 2022;12:2426. https:\/\/doi.org\/10.3390\/diagnostics12102426.","journal-title":"Diagnostics"},{"key":"5051_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12944-022-01712-z","volume":"21","author":"S Lu","year":"2022","unstructured":"Lu S, Kuang M, Yue J, Hu C, Sheng G, Zou Y. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population. Lipids Health Dis. 2022;21:95. https:\/\/doi.org\/10.1186\/s12944-022-01712-z.","journal-title":"Lipids Health Dis"},{"key":"5051_CR27","doi-asserted-by":"publisher","first-page":"1457589","DOI":"10.3389\/fendo.2024.1457589","volume":"15","author":"Y Xuan","year":"2024","unstructured":"Xuan Y, Zhu M, Xu L, Huangfu S, Li T, Liu C, et al. Elevated non-HDL-C to HDL-C ratio as a marker for NAFLD and liver fibrosis risk: a cross-sectional analysis. Front Endocrinol. 2024;15:1457589. https:\/\/doi.org\/10.3389\/fendo.2024.1457589.","journal-title":"Front Endocrinol"},{"key":"5051_CR28","doi-asserted-by":"publisher","first-page":"12990","DOI":"10.1038\/s41598-024-82012-7","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Wang R. The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a predictor of NAFLD prevalence and steatosis severity. Sci Rep. 2025;15:12990. https:\/\/doi.org\/10.1038\/s41598-024-82012-7.","journal-title":"Sci Rep"},{"key":"5051_CR29","doi-asserted-by":"publisher","first-page":"1557751","DOI":"10.3389\/fnut.2025.1557751","volume":"12","author":"D Yang","year":"2025","unstructured":"Yang D, Dai H, Wang Y, Zhang J, Wei M, Shan M, et al. Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease. Front Nutr. 2025;12:1557751. https:\/\/doi.org\/10.3389\/fnut.2025.1557751.","journal-title":"Front Nutr"},{"key":"5051_CR30","doi-asserted-by":"publisher","first-page":"1655817","DOI":"10.3389\/fnut.2025.1655817","volume":"12","author":"C Sun","year":"2025","unstructured":"Sun C, Si K, Zhu Y, Li C, Yu Y, Jia C, et al. Assessing the association between the non-HDL to HDL cholesterol ratio and NAFLD in Chinese adults: concentrate on gout populations. Front Nutr. 2025;12:1655817. https:\/\/doi.org\/10.3389\/fnut.2025.1655817.","journal-title":"Front Nutr"},{"key":"5051_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12944-018-0720-x","volume":"17","author":"D Wang","year":"2018","unstructured":"Wang D, Wang L, Wang Z, Chen S, Ni Y, Jiang D. Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis. Lipids Health Dis. 2018;17:67. https:\/\/doi.org\/10.1186\/s12944-018-0720-x.","journal-title":"Lipids Health Dis"},{"key":"5051_CR32","unstructured":"Gao S, Ramen K, Yu S, Luo J. Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: secondary analysis based on a longitudinal study. Int J Clin Exp Pathol. 2020;13(10):2569\u201375. https:\/\/pubmed.ncbi.nlm.nih.gov\/33165444\/. PMID: 33165444; PMCID: PMC7642706."},{"key":"5051_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12944-020-01421-5","volume":"19","author":"S Yang","year":"2020","unstructured":"Yang S, Zhong J, Ye M, Miao L, Lu G, Xu C, et al. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. Lipids Health Dis. 2020;19:242. https:\/\/doi.org\/10.1186\/s12944-020-01421-5.","journal-title":"Lipids Health Dis"},{"key":"5051_CR34","doi-asserted-by":"publisher","first-page":"24847","DOI":"10.1038\/s41598-024-76002-y","volume":"14","author":"X Huang","year":"2024","unstructured":"Huang X, Li J, Zhang L, Zhang C, Li C. The association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in US adults: a cross-sectional study. Sci Rep. 2024;14:24847. https:\/\/doi.org\/10.1038\/s41598-024-76002-y.","journal-title":"Sci Rep"},{"key":"5051_CR35","doi-asserted-by":"publisher","first-page":"1585811","DOI":"10.3389\/fendo.2025.1585811","volume":"16","author":"H Chen","year":"2025","unstructured":"Chen H, Miao X, Hu M, Song Z, He Y, Deng J, et al. Associations between high-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and their ratio with metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study. Front Endocrinol. 2025;16:1585811. https:\/\/doi.org\/10.3389\/fendo.2025.1585811.","journal-title":"Front Endocrinol"},{"key":"5051_CR36","doi-asserted-by":"publisher","first-page":"1508106","DOI":"10.3389\/fnut.2025.1508106","volume":"11","author":"J Li","year":"2025","unstructured":"Li J, Kou C, Chai Y, Li Y, Liu X, Zhang L, et al. The relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and both MASLD and advanced liver fibrosis: evidence from NHANES 2017\u20132020. Front Nutr. 2025;11:1508106. https:\/\/doi.org\/10.3389\/fnut.2025.1508106.","journal-title":"Front Nutr"},{"key":"5051_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12944-018-0940-0","volume":"17","author":"T An","year":"2018","unstructured":"An T, Song Y, Yang Y, Guo M, Liu H, Liu K, et al. Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population. Lipids Health Dis. 2018;17:296. https:\/\/doi.org\/10.1186\/s12944-018-0940-0.","journal-title":"Lipids Health Dis"},{"key":"5051_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3126\/kumj.v19i3.49712","volume":"19","author":"A Shahi","year":"2021","unstructured":"Shahi A, Gautam N, Rawal S, Sharma U, Jayan A. Lipid Profile and Ultrasonographic Grading in Alcoholic and Non Alcoholic Fatty Liver Patients. Kathmandu Univ Med J. 2021;19:334\u20138. https:\/\/doi.org\/10.3126\/kumj.v19i3.49712.","journal-title":"Kathmandu Univ Med J"},{"key":"5051_CR39","doi-asserted-by":"publisher","first-page":"8462","DOI":"10.1038\/s41598-025-90818-2","volume":"15","author":"X Yang","year":"2025","unstructured":"Yang X, Yan H, Guo R, Chen Y. Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study. Sci Rep. 2025;15:8462. https:\/\/doi.org\/10.1038\/s41598-025-90818-2.","journal-title":"Sci Rep"},{"key":"5051_CR40","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12944-024-02309-4","volume":"23","author":"J Liu","year":"2024","unstructured":"Liu J, Oorloff MD, Nadella A, Guo P, Ye M, Wang X, et al. Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Lipids Health Dis. 2024;23:324. https:\/\/doi.org\/10.1186\/s12944-024-02309-4.","journal-title":"Lipids Health Dis"},{"key":"5051_CR41","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0140-6736(23)01174-1","volume":"402","author":"M Serra-Burriel","year":"2023","unstructured":"Serra-Burriel M, Juanola A, Serra-Burriel F, Thiele M, Graupera I, Pose E, et al. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study. Lancet Lond Engl. 2023;402:988\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(23)01174-1.","journal-title":"Lancet Lond Engl"},{"key":"5051_CR42","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.jhepr.2024.101092","volume":"6","author":"F Bril","year":"2024","unstructured":"Bril F, Kalavalapalli S, Lomonaco R, Frye R, Godinez Leiva E, Cusi K. Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants. JHEP Rep. 2024;6:101092. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101092.","journal-title":"JHEP Rep"},{"key":"5051_CR43","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jhep.2024.12.045","volume":"82","author":"D Barb","year":"2025","unstructured":"Barb D, Kalavalapalli S, Godinez Leiva E, Bril F, Huot-Marchand P, Dzen L, et al. Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD. J Hepatol. 2025;82:979\u201391. https:\/\/doi.org\/10.1016\/j.jhep.2024.12.045.","journal-title":"J Hepatol"},{"key":"5051_CR44","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.5551\/jat.63118","volume":"29","author":"H Hu","year":"2022","unstructured":"Hu H, Fukunaga A, Yokoya T, Nakagawa T, Honda T, Yamamoto S, et al. Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease: The Japan Epidemiology Collaboration on Occupational Health Study. J Atheroscler Thromb. 2022;29:1295\u2013306. https:\/\/doi.org\/10.5551\/jat.63118.","journal-title":"J Atheroscler Thromb"},{"key":"5051_CR45","doi-asserted-by":"publisher","first-page":"101687","DOI":"10.1016\/j.jhepr.2025.101687","volume":"8","author":"Z Liang","year":"2026","unstructured":"Liang Z, Jin H, Gao W, Hu X, Li R, Zhang H, et al. Plasma IGFBP7 improves risk reclassification for liver-related outcomes: Insights from proteo-transcriptomic profiling. JHEP Rep Innov Hepatol. 2026;8:101687. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101687.","journal-title":"JHEP Rep Innov Hepatol"},{"key":"5051_CR46","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1002\/hep.26988","volume":"59","author":"F Bril","year":"2014","unstructured":"Bril F, Lomonaco R, Orsak B, Ortiz-Lopez C, Webb A, Tio F, et al. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. Hepatol Baltim Md. 2014;59:2178\u201387. https:\/\/doi.org\/10.1002\/hep.26988.","journal-title":"Hepatol Baltim Md"},{"key":"5051_CR47","doi-asserted-by":"publisher","first-page":"e70132","DOI":"10.1002\/edm2.70132","volume":"8","author":"DM Miller","year":"2025","unstructured":"Miller DM, McCauley KF, Dunham-Snary KJ. Metabolic Dysfunction\u2010Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances. Endocrinol Diabetes Metab. 2025;8:e70132. https:\/\/doi.org\/10.1002\/edm2.70132.","journal-title":"Endocrinol Diabetes Metab"},{"key":"5051_CR48","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.jhepr.2024.101185","volume":"6","author":"F Carli","year":"2024","unstructured":"Carli F, Della Pepa G, Sabatini S, Vidal Puig A, Gastaldelli A. Lipid metabolism in MASLD and MASH: From mechanism to the clinic. JHEP Rep. 2024;6:101185. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101185.","journal-title":"JHEP Rep"},{"key":"5051_CR49","doi-asserted-by":"crossref","unstructured":"Fisher EA, Feig JE, Hewing B, Hazen SL, Smith D. HDL Function, Dysfunction, and Reverse Cholesterol Transport. 2013.","DOI":"10.1161\/ATVBAHA.112.300133"},{"key":"5051_CR50","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335\u201347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004.","journal-title":"Hepatology"},{"key":"5051_CR51","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","volume":"48","author":"Y Kawano","year":"2013","unstructured":"Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol. 2013;48:434\u201341. https:\/\/doi.org\/10.1007\/s00535-013-0758-5.","journal-title":"J Gastroenterol"},{"key":"5051_CR52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.32604\/biocell.2025.059908","volume":"49","author":"J Yang","year":"2025","unstructured":"Yang J, Zhang J, Zhang L, Yang Z. Mitochondrial Oxidative Stress-Associated Mechanisms in the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease. Biocell. 2025;49:399\u2013417. https:\/\/doi.org\/10.32604\/biocell.2025.059908.","journal-title":"Biocell"},{"key":"5051_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","volume":"14","author":"JL Yecies","year":"2011","unstructured":"Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, et al. Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways. Cell Metab. 2011;14:21\u201332. https:\/\/doi.org\/10.1016\/j.cmet.2011.06.002.","journal-title":"Cell Metab"},{"key":"5051_CR54","doi-asserted-by":"publisher","first-page":"964","DOI":"10.4093\/dmj.2025.0644","volume":"49","author":"XT Truong","year":"2025","unstructured":"Truong XT, Lee DH. Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications. Diabetes Metab J. 2025;49:964\u201386. https:\/\/doi.org\/10.4093\/dmj.2025.0644.","journal-title":"Diabetes Metab J"},{"key":"5051_CR55","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","volume":"36","author":"T Bo","year":"2024","unstructured":"Bo T, Gao L, Yao Z, Shao S, Wang X, Proud CG, et al. Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease. Cell Metab. 2024;36:947\u201368. https:\/\/doi.org\/10.1016\/j.cmet.2024.04.006.","journal-title":"Cell Metab"},{"key":"5051_CR56","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wai-Sun Wong V, Wright E, et al. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2021;161:1657\u201369. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.049.","journal-title":"Gastroenterology"},{"key":"5051_CR57","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.jacc.2024.07.034","volume":"84","author":"E Bj\u00f6rnson","year":"2024","unstructured":"Bj\u00f6rnson E, Adiels M, Gummesson A, Taskinen M-R, Burgess S, Packard CJ, et al. Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol. J Am Coll Cardiol. 2024;84:1328\u201338. https:\/\/doi.org\/10.1016\/j.jacc.2024.07.034.","journal-title":"J Am Coll Cardiol"},{"key":"5051_CR58","doi-asserted-by":"publisher","first-page":"985","DOI":"10.5551\/jat.RV17025","volume":"25","author":"M Nagao","year":"2018","unstructured":"Nagao M, Nakajima H, Toh R, Hirata K, Ishida T. Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action. J Atheroscler Thromb. 2018;25:985\u201393. https:\/\/doi.org\/10.5551\/jat.RV17025.","journal-title":"J Atheroscler Thromb"},{"key":"5051_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14218\/JCTH.2019.00028","volume":"7 X","author":"DH Akhtar","year":"2019","unstructured":"Akhtar DH, Iqbal U, Vazquez-Montesino LM, Dennis BB, Ahmed A. Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol. 2019;7 X:1\u20139. https:\/\/doi.org\/10.14218\/JCTH.2019.00028.","journal-title":"J Clin Transl Hepatol"},{"key":"5051_CR60","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001749","author":"Z Liang","year":"2026","unstructured":"Liang Z, Jin H, Gao W, Hu X, Xi Y, Zhang H, et al. Prospective head-to-head comparison of routine non-invasive scores for predicting severe cirrhosis-related morbidity in the general population. Hepatol Baltim Md. 2026. https:\/\/doi.org\/10.1097\/HEP.0000000000001749.","journal-title":"Hepatol Baltim Md"},{"key":"5051_CR61","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/nu17050776","volume":"17","author":"H Berisha","year":"2025","unstructured":"Berisha H, Hattab R, Comi L, Giglione C, Migliaccio S, Magni P. Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk. Nutrients. 2025;17:776. https:\/\/doi.org\/10.3390\/nu17050776.","journal-title":"Nutrients"},{"key":"5051_CR62","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12944-024-02278-8","volume":"23","author":"Y Lian","year":"2024","unstructured":"Lian Y, Luo P. The association between different leisure-time physical activity patterns and the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in adults: national health and nutrition examination survey 2007\u20132018. Lipids Health Dis. 2024;23:336. https:\/\/doi.org\/10.1186\/s12944-024-02278-8.","journal-title":"Lipids Health Dis"},{"key":"5051_CR63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3348\/kjr.2025.0966","volume":"27","author":"SM Chan","year":"2026","unstructured":"Chan SM, Martins VF, Marsh K, Wang K, Weeks JT, Han A, et al. Imaging Evaluation for Steatotic Liver Disease. Korean J Radiol. 2026;27:137. https:\/\/doi.org\/10.3348\/kjr.2025.0966.","journal-title":"Korean J Radiol"},{"key":"5051_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/flgastro-2018-101139","volume":"11","author":"A Boyd","year":"2020","unstructured":"Boyd A, Cain O, Chauhan A, Webb GJ. Medical liver biopsy: background, indications, procedure and histopathology. Frontline Gastroenterol. 2020;11:40\u20137. https:\/\/doi.org\/10.1136\/flgastro-2018-101139.","journal-title":"Frontline Gastroenterol"},{"key":"5051_CR65","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/medicina61040736","volume":"61","author":"J Fr\u0105czek","year":"2025","unstructured":"Fr\u0105czek J, Sowa A, Agopsowicz P, Migacz M, Dyli\u0144ska-Kala K, Holecki M. Non-Invasive Tests as a Replacement for Liver Biopsy in the Assessment of MASLD. Med (Mex). 2025;61:736. https:\/\/doi.org\/10.3390\/medicina61040736.","journal-title":"Med (Mex)"},{"key":"5051_CR66","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12876-024-03471-w","volume":"24","author":"X Ma","year":"2024","unstructured":"Ma X, Jia J, Cui H, Zhou J, Tian F, Yang J, et al. Association between the triglyceride to high density lipoprotein cholesterol ratio and the incidence of metabolic dysfunction-associated fatty liver disease: a retrospective cohort study. BMC Gastroenterol. 2024;24:389. https:\/\/doi.org\/10.1186\/s12876-024-03471-w.","journal-title":"BMC Gastroenterol"},{"key":"5051_CR67","doi-asserted-by":"publisher","first-page":"1591241","DOI":"10.3389\/fendo.2025.1591241","volume":"16","author":"J Yuan","year":"2025","unstructured":"Yuan J, He X, Lu Y, Pu X, Liu L, Zhang X, et al. Triglycerides\/high-density lipoprotein-cholesterol ratio outperforms traditional lipid indicators in predicting metabolic dysfunction-associated steatotic liver disease among U.S. adults. Front Endocrinol. 2025;16:1591241. https:\/\/doi.org\/10.3389\/fendo.2025.1591241.","journal-title":"Front Endocrinol"},{"key":"5051_CR68","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","volume":"67","author":"H Hagstr\u00f6m","year":"2017","unstructured":"Hagstr\u00f6m H, Nasr P, Ekstedt M, Hammar U, St\u00e5l P, Hultcrantz R, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol. 2017;67:1265\u201373. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.027.","journal-title":"J Hepatol"},{"key":"5051_CR69","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","volume":"23","author":"H Zheng","year":"2024","unstructured":"Zheng H, Sechi LA, Navarese EP, Casu G, Vidili G. Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review. Cardiovasc Diabetol. 2024;23:346. https:\/\/doi.org\/10.1186\/s12933-024-02434-5.","journal-title":"Cardiovasc Diabetol"},{"key":"5051_CR70","doi-asserted-by":"publisher","first-page":"e70221","DOI":"10.1111\/jch.70221","volume":"28","author":"Y Huang","year":"2026","unstructured":"Huang Y, Gao Y, Shao J, Wang K, Ma Y, Ai L, et al. Association Between NHHR and Future Cardiovascular Disease Among Patients With CKM Stages 0\u20133: A Nationwide Prospective Cohort Study. J Clin Hypertens. 2026;28:e70221. https:\/\/doi.org\/10.1111\/jch.70221.","journal-title":"J Clin Hypertens"},{"key":"5051_CR71","doi-asserted-by":"publisher","first-page":"1712473","DOI":"10.3389\/fendo.2026.1712473","volume":"17","author":"X Kong","year":"2026","unstructured":"Kong X, Yuan X, Wang H, Zhao M, Jing W. Prognostic value of admission NHHR for functional recovery in acute ischemic stroke. Front Endocrinol. 2026;17:1712473. https:\/\/doi.org\/10.3389\/fendo.2026.1712473.","journal-title":"Front Endocrinol"},{"key":"5051_CR72","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12944-024-02262-2","volume":"23","author":"Q Cheng","year":"2024","unstructured":"Cheng Q, Wang Z, Zhong H, Zhou S, Liu C, Sun J, et al. Association of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and gallstones among US adults aged\u2009\u2264\u200950 years: a cross-sectional study from NHANES 2017\u20132020. Lipids Health Dis. 2024;23:265. https:\/\/doi.org\/10.1186\/s12944-024-02262-2.","journal-title":"Lipids Health Dis"},{"key":"5051_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13098-025-01637-4","volume":"17","author":"S Wen","year":"2025","unstructured":"Wen S, Li J, Xie Z, Chen X, Li J, Lin X. The role of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (nhhr) in prediabetes progression and the mediating effect of BMI: a longitudinal study in China. Diabetol Metab Syndr. 2025;17:67. https:\/\/doi.org\/10.1186\/s13098-025-01637-4.","journal-title":"Diabetol Metab Syndr"},{"key":"5051_CR74","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1111\/liv.16096","volume":"44","author":"Z Pan","year":"2024","unstructured":"Pan Z, Yilmaz Y, Al-Busafi SA, Eslam M. The MAFLD definition identifies three homogenous groups of patients. Liver Int Off J Int Assoc Study Liver. 2024;44:3287\u20139. https:\/\/doi.org\/10.1111\/liv.16096.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"5051_CR75","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/gutjnl-2025-336127","volume":"75","author":"Z Huo","year":"2026","unstructured":"Huo Z, Chen Y, Huang Y, Yang Z, Long Y, Zhang Q, et al. Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts. Gut. 2026;75:772\u201385. https:\/\/doi.org\/10.1136\/gutjnl-2025-336127.","journal-title":"Gut"},{"key":"5051_CR76","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s12072-024-10721-2","volume":"18","author":"M Jiang","year":"2024","unstructured":"Jiang M, Pan Z, George J, Eslam M. Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD. Hepatol Int. 2024;18:1731\u20139. https:\/\/doi.org\/10.1007\/s12072-024-10721-2.","journal-title":"Hepatol Int"},{"key":"5051_CR77","doi-asserted-by":"publisher","unstructured":"Drygalski K. Pharmacological Treatment of MASLD: Contemporary Treatment and Future Perspectives. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/ijms26136518.","DOI":"10.3390\/ijms26136518"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05051-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:51:44Z","timestamp":1789602704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05051-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5051"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05051-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"573"}}